Skip to main content
Watch Insiders
AMRXHealthcare

Amneal Pharmaceuticals Inc (AMRX) Insider Trading

In the last 90 days, 3 Amneal Pharmaceuticals Inc (AMRX) insiders reported no open-market purchases and 3 sales totaling $7,216,576. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 13, 2026John KielyCorporate insiderSale50,000$17.64$882,000
Aug 12, 2026Nikita ShahExecutive Vice PresidentSale146,403$17.51$2,563,517
Aug 12, 2026Jason B. DalyEVP, Chief Legal OfficerSale216,613$17.41$3,771,059
May 11, 2026Deborah M. AutorCorporate insiderSale34,819$12.94$450,558

Common questions

AMRX insider trading FAQ

Are AMRX insiders buying or selling?
Over the last 90 days, AMRX insiders were net sellers, reporting $0.00 of open-market purchases and $7,216,576 of sales.
When was the last AMRX insider purchase?
No open-market insider purchase of Amneal Pharmaceuticals Inc stock was reported in the last 90 days.
Where does AMRX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Amneal Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.